Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1721980 | 0.96 | CA1 (0.35) | CA2CA1CA7CA13TSHR | |
| SCHEMBL103406 | 0.84 | CA2 (0.33) | CA2CA1CA7CA13TSHR | |
| SCHEMBL584868 | 0.84 | CA2 (0.41) | CA2CA1CA7CA13TSHR | |
| SCHEMBL867361 | 0.84 | CA2 (0.39) | CA2CA1CA7CA13TSHR | |
| SCHEMBL1470291 | 0.81 | CA1 (0.32) | CA2CA1CA7CA13 | |
| SCHEMBL1468423 | 0.81 | CA1 (0.32) | CA2CA1CA7CA13 | |
| SCHEMBL11788241 | 0.81 | CA2 (0.43) | CA2CA1CA7CA13 | |
| SCHEMBL13684270 | 0.81 | CA2 (0.43) | CA2CA1CA7CA13 | |
| SCHEMBL1470100 | 0.81 | CA1 (0.32) | CA2CA1CA7CA13 | |
| SCHEMBL9856311 | 0.80 | TSHR (0.39) | TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1568725-B1 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS SPA (IT) | 2008-06-18 | — | — | EP | claimed |
| US-7371900-B2 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. (IT) | 2008-05-13 | — | — | US | claimed |
| US-20050197469-A1 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. | 2005-09-08 | — | — | US | claimed |
| EP-1568725-A1 | Peroxidic perfluoropolyethers | Solvay Solexis S.p.A. (IT) | 2005-08-31 | — | — | EP | claimed |
| EP-4733293-A1 | METHOD FOR PRODUCING ALKYL FLUORIDE COMPOUND, AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALKYL FLUORIDE COMPOUND | Mitsubishi Materials Electronic Chemicals Co., Ltd. (JP) | 2026-04-29 | — | — | EP | disclosed |
| WO-2025022805-A1 | AMINO GROUP ELIMINATING AGENT, REACTION PRODUCT PRODUCTION METHOD, REACTION PRECURSOR, REACTION PRECURSOR PRODUCTION METHOD, AND METHOD FOR PRODUCING OPTICALLY ACTIVE REACTION PRODUCT | 三菱マテリアル電子化成株式会社 | 2025-01-30 | — | — | WO | disclosed |
| WO-2024262208-A1 | METHOD FOR PRODUCING ALKYL FLUORIDE COMPOUND, AND METHOD FOR PRODUCING OPTICALLY ACTIVE ALKYL FLUORIDE COMPOUND | 三菱マテリアル電子化成株式会社 | 2024-12-26 | — | — | WO | disclosed |
| US-20240194948-A1 | FLUORINE-CONTAINING CYCLIC SULFONYLIMIDE SALT, AND METHOD FOR PRODUCING SAME, NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS SECONDARY BATTERY | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2024-06-13 | — | — | US | disclosed |
| EP-4317129-A1 | FLUORINE-CONTAINING CYCLIC SULFONYLIMIDE SALT, AND METHOD FOR PRODUCING SAME, NON-AQUEOUS ELECTROLYTE, NON-AQUEOUS SECONDARY BATTERY | Asahi Kasei Kabushiki Kaisha (JP) | 2024-02-07 | — | — | EP | disclosed |
| EP-3557684-B1 | LITHIUM SECONDARY BATTERIES AND NONAQUEOUS ELECTROLYTE FOR USE IN THE SAME | MITSUBISHI CHEM CORP (JP) | 2024-01-24 | — | — | EP | disclosed |
| US-20230378435-A1 | LITHIUM SECONDARY BATTERIES AND NONAQUEOUS ELECTROLYTE FOR USE IN THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-11-23 | — | — | US | disclosed |
| US-11769871-B2 | Lithium secondary batteries and nonaqueous electrolyte for use in the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-09-26 | — | — | US | disclosed |
| US-20080194881-A1 | Copolymers having functional end groups of sulfonyl fluorides and acyl fluorides; macromer promoters useful for both condensation and addition polymerizations for elastomers and polymershaving a crystal structure; mechanical properties; lubricants for magnetic disks; adhesives | SOLVAY SOLEXIS S.P.A. (IT) | 2008-08-14 | — | — | US | disclosed |
| EP-1939971-A1 | LITHIUM SECONDARY CELL AND NONAQUEOUS ELECTROLYTIC SOLUTION FOR USE THEREIN | Mitsubishi Chemical Corporation (JP) | 2008-07-02 | — | — | EP | disclosed |
| EP-1568725-B1 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS SPA (IT) | 2008-06-18 | — | — | EP | disclosed |
| US-7371900-B2 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. (IT) | 2008-05-13 | — | — | US | disclosed |
| US-20070224514-A1 | Nonaqueous Electrolyte Solution and Lithium Secondary Battery Using Same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-09-27 | — | — | US | disclosed |
| EP-1744394-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND LITHIUM SECONDARY BATTERY USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2007-01-17 | — | — | EP | disclosed |
| US-20050197469-A1 | Peroxidic perfluoropolyethers | SOLVAY SOLEXIS S.P.A. | 2005-09-08 | — | — | US | disclosed |
| EP-1568725-A1 | Peroxidic perfluoropolyethers | Solvay Solexis S.p.A. (IT) | 2005-08-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080194881-A1 | Copolymers having functional end groups of sulfonyl fluorides and acyl fluorides; macromer promoters useful for both condensation and addition polymerizations for elastomers and polymershaving a crystal structure; mechanical properties; lubricants for magnetic disks; adhesives | FOXO1, FOXM1, F12 | CA2 1034/4885CA1 229/4885CA7 2752/4885 |
| US-20050197469-A1 | Peroxidic perfluoropolyethers | PRDX2, PRDX1, PRXL2A | CA2 737/4885CA1 758/4885CA7 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.